Maarten van der Linden

Author

University Medical Center Utrecht ORCID

Also Known As

M Lindén, M. van der Linden, Maarten van der Linden

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Oncode Institute The Netherlands Cancer Institute St. Antonius Ziekenhuis

About

Maarten van der Linden is an author at University Medical Center Utrecht specializing in medicine, immunology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	299
2	Allergy	2	2	158
3	Biochemistry	2	2	70
4	Engineering	1	1	16
5	Natural Sciences	1	1	16

Maarten van der Linden

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Long‐term expanding human airway organoids for disease modeling Norman Sachs, Angelos Papaspyropoulos, Domenique D. Zomer-van Ommen, The EMBO Journal	2019	1K
Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases Renato G.S. Chirivi, Jos W.G. van Rosmalen, Maarten van der Linden, Cellular and Molecular Immunology ImmunologyImmune RegulationNet ReleaseInnate ImmunityImmunotherapy	2020	142
Differential Signalling and Kinetics of Neutrophil Extracellular Trap Release Revealed by Quantitative Live Imaging Maarten van der Linden, Geertje H. A. Westerlaken, Michiel van der Vlist, Scientific Reports	2017	102
Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome Maarten van der Linden, Lucas L. van den Hoogen, Geertje H. A. Westerlaken, Lara D. Veeken	2018	92
CXCL4 drives fibrosis by promoting several key cellular and molecular processes Alsya J. Affandi, Tiago Carvalheiro, Andrea Ottria, Cell Reports Inflammatory Lung DiseaseLung InflammationImmunologyPathologyFibrosis Development	2022	71
mTOR inhibition by metformin impacts monosodium urate crystal–induced inflammation and cell death in gout: a prelude to a new add-on therapy? Nadia Vazirpanah, Andrea Ottria, Maarten van der Linden, Annals of the Rheumatic Diseases	2019	65
Signal Inhibitory Receptor on Leukocytes-1 Limits the Formation of Neutrophil Extracellular Traps, but Preserves Intracellular Bacterial Killing Kristof Van Avondt, Maarten van der Linden, Paul H. Naccache, The Journal of Immunology	2016	57
Neutrophil killing of two type 1 fimbria-bearing Escherichia coli strains: dependence on respiratory burst activation Ronny Lock, Cláes Dahlgren, Maarten van der Linden, Infection and Immunity BacteriologyImmunologyRedox BiologyRespiratory Burst ActivationOxidative Stress	1990	54
Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes‐1 negatively regulates human neutrophils Matevž Rumpret, Helen J. von Richthofen, Maarten van der Linden, European Journal of Immunology	2021	25
POSH2 is a RING finger E3 ligase with Rac1 binding activity through a partial CRIB domain Satu Kärkkäinen, Maarten van der Linden, G. Herma Renkema FEBS Letters	2010	23

Page 1